Abstract
The α2-adrenergic receptors (α2-ARs) mediate signals to intracellular second messengers via guanine nucleotide binding proteins. Three human genes encoding α2-AR subtypes (α2A, α2B, α2C) have been cloned. Several chemical compounds display subtype differences in their binding and/or functional activity. Site-directed mutagenesis and molecular modeling are new tools with which to investigate the subtype selectivity of ligands. In this study, we introduce a new approach to mapping of the binding site crevice of the human α2A-AR. Based on a three-dimensional receptor model, we systematically mutated residues 197–201 and 204 in the fifth transmembrane domain of the human α2A-AR to cysteine. Chloroethylclonidine, an alkylating derivative of the α2-adrenergic agonist clonidine, binds irreversibly to α2A-ARs by forming a covalent bond with the sulfhydryl side chain of a cysteine residue exposed in the binding cavity, leading to inactivation of the receptor. Irreversible binding of chloroethylclonidine was used as a criterion for identifying introduced cysteine residues as being exposed in the binding cavity. The results supported a receptor model in which the fifth transmembrane domain is α-helical, with residues Val197, Ser200, Cys201, and Ser204 exposed in the binding pocket. Residues Ile198, Ser199, Ile202, and Gly203 face the lipid bilayer of the plasma membrane. This approach emerges as a powerful tool for structural characterization of the α2-ARs.
Footnotes
- Received July 21, 1997.
- Accepted October 8, 1997.
-
Send reprint requests to: Dr. Anne Marjamäki, MediCity Research Laboratory, City of Turku, Tykistökatu 6 A, FIN-20520, Turku, Finland. E-mail: anmarja{at}utu.fi
-
↵1 Current affiliation: Juvantia Pharma, Tykistökatu 6 A, FIN-20520 Turku, Finland.
-
This work was supported by the Academy of Finland and Technology Development Centre of Finland.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|